• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

Solutions


From raising venture capital to taking companies public, supporting acquisition strategies to advising management buy-outs or finding strategic partners, Bryan Garnier supports clients and their investors at every stage of their growth and investing journeys.​ Bryan Garnier’s holistic approach to advising clients on the full range of equity, debt and M&A transactions creates a true client-first model, building long-term relationships over the full business lifecycle.

M&A Advisory


Private Capital Solutions


Debt Solutions

Public Capital Solutions


Institutional Sales and Trading

Hide filtersShow filters
× Close

Sectors

  • (218)
  • (177)
  • (106)
  • (96)
  • (48)

Deal Type

  • (298)
  • (141)
  • (141)
  • (7)

Clear all Apply

Bryan, Garnier & Co acts as Sole Financial Advisor to Physidia and its shareholders, a leading European renal care medtech company providing home haemodialysis solutions, on the sale of a majority stake to Columna Capital

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Medincell’s EUR 25 million Follow-on Offering

Bryan, Garnier & Co acts as the sole financial advisor to the shareholders of Tinqin on their recent sale to be ys

Bryan, Garnier & Co advises Carlyle on its investment in Groupe Lacour

Bryan, Garnier & Co acts as Sole Financial Advisor to the software company Groupe Positive (ex- Groupe Sarbacane) and its shareholders on its €110m fundraise led by EMZ

Bryan, Garnier & Co acts as Sole Financial Advisor to the digital-native staffing platform Gojob on its €23 million Series C fundraise

Bryan, Garnier & Co acted as the Financial Advisor to Shark Solutions, global leader in manufacturing recycled PVB post consumer use, successfully completing the Company’s €20m private placements led by AXA Investment Managers Alts’ Impact Fund

Bryan, Garnier & Co acts as Sole Financial Advisor to Ekoscan Integrity and its shareholders on its €23m fundraising from private equity firm Abénex, alongside new and historical strategics (EDF Pulse and ALIAD, the innovative investment arms of EDF and Air Liquide respectively)

Bryan, Garnier & Co acted as Sole Financial Advisor to New Alpha Verto on its investment in GAC Technology

Bryan, Garnier & Co acts as Sole Financial Advisor to Ganymed Robotics, a developer of computer vision software and robotics technologies for orthopedic surgeons, on its first €21 million closing of its oversubscribed Fundraising

Bryan, Garnier & Co acted as Sole Financial Advisor to Vade and its shareholders on its €28m fundraising from Tikehau Ace Capital, Bpifrance and Auriga Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to Enapter AG on a €20m strategic investment from Johnson Matthey

  • 1
  • 2
  • 3
  • 4
  • …
  • 12

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • BCI – Made in France 2025 – Hosted by Bryan, Garnier & Co
  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }